Background
The 13C-urea breath test (UBT) is a simple test for the diagnosis of Helicobacter pylori infection, but several factors have been reported to affect the results of this test. In this study, the effects of the anti-ulcer drugs used in Japan on the results of the UBT were determined.
Methods
The subjects of the study were 64 adult volunteers who tested positive for H. pylori infection by the serum antibody method. Eight classes of anti-ulcer drugs used in Japan were administered at their usual doses to these subjects: lansoprazole, a proton pump inhibitor (PPI); nizatidine, an H2-receptor antagonist (H2RA); and polaprezinc, ecabet sodium, rebamipide, teprenone, cetraxate hydrochloride, and sucralfate, all mucoprotective agents. The study drugs were randomized for administration to the subjects, and each of the drugs was administered for 14 consecutive days. The UBT was performed on days 0, 14, and 21.
Results
The mean Δ13C‰ in the lansoprazole group was significantly decreased on day 14, to below 10‰, in 4 of 16 subjects, and in 1 of the 4 subjects, the test result was negative, with the Δ13C‰ falling to 1.7‰. The value returned to baseline 1 week after the discontinuation of lansoprazole. The other drugs administered had no significant effect on the result of the UBT, except that the mean Δ13C‰ showed a tendency to decrease after the administration of ecabet sodium and rebamipide.
Conclusions
Administration of a PPI may produce a false-negative UBT result, while other anti-ulcer drugs, for the most part, have little effect on the result of the UBT when used alone.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murakami, K., Sato, R., Okimoto, T. et al. Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol 38, 937–941 (2003). https://doi.org/10.1007/s00535-003-1176-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-003-1176-x